PE/Cyanine7 anti-mouse/human CD44 Antibody

Product Details

Verified Reactivity

Mouse, Human

Reported Reactivity

Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat

Antibody Type

Monoclonal

Host Species

Rat

Immunogen

Dexamethasone-induced myeloid leukemia M1 cells

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.

Preparation

The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.

Concentration

0.2 mg/ml

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 10⁶ cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser

Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)

Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD44^17,18 that is located between amino acids 145 and 186²⁰. This clone has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections^6,7, complement-mediated cytotoxicity¹, immunoprecipitation^1,3, in vivo inhibition of DTH^4,5, and spatial biology (IBEX)^23,24. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Additional Product Notes

BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.

Application References

1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
8. Lee JW, et al. 2006. Nature Immunol. 8:181.
9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
12. Wang XY, et al. 2008. Blood 111:2436. PubMed
13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
14. Yamazaki J, et al. 2009. Blood PubMed
15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
20. Sandmaier BM, et al. 1998. Blood 91:3494.
21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed

Product Citations

1. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
2. Jayachandran R, et al. 2019. Immunity. 50:152. PubMed
3. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
4. Gerber AN, et al. 2021. Cell Rep. 37:109816. PubMed
5. Hu J, et al. 2022. J Immunother Cancer. 10:. PubMed
6. Koh CH, et al. 2020. Cancer Immunol Res. 8:698. PubMed
7. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
8. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
9. Chen H, et al. 2005. J Immunol. 175:591. PubMed
10. Shimizu K, et al. 2020. Molecular Cell. 77(5):937-950.e6.. PubMed
11. Wabitsch S, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1166. PubMed
12. He X, et al. 2021. Cell Rep. 36:109674. PubMed
13. Wang D, et al. 2018. Immunity. 48:659. PubMed
14. Zhang P et al. 2019. Cell Rep. 27(11):3117-3123 . PubMed
15. Aldon Y, et al. 2020. J Immunol. 204:903. PubMed
16. Baranek T, et al. 2020. Cell Reports. 32(10):108116. PubMed
17. Almeida D, et al. 2010. J Immunol. 185:1927. PubMed
18. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
19. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
20. Feizi N, et al. 2021. Cell Death Dis. 12:1026. PubMed
21. Pal D et al. 2017. eLife. 6 pii: e21615. PubMed
22. Bhattacharjee S, et al. 2019. Cell Rep. 28:231. PubMed
23. Gotoh K et al. 2018. Cell reports. 25(7):1800-1815 . PubMed
24. Gondek D, et al. 2012. J Immunol. 189:2441. PubMed
25. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
26. Li Y, et al. 2020. Nat Commun. 11:2781. PubMed
27. Zhan CS, et al. 2020. FASEB J. 14006:34. PubMed
28. LaMothe RA et al. 2018. Front Immunol. 0.570138889 . PubMed
29. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
30. Bolinger B, et al. 2013. J Immunol. 190:4162. PubMed
31. Kersh A, et al. 2014. J Immunol. 193:4429. PubMed
32. Han Y, et al. 2019. Am J Cancer Res. 9:800. PubMed
33. Ueda R, et al. 2009. Clin Cancer Res. 5.215972222. PubMed
34. Ruf B, et al. 2021. Cancer Immunol Res. 9:1024. PubMed
35. Stewart JM, et al. 2020. ACS Biomater Sci Eng. 6:5941. PubMed
36. Nanou A, et al. 2020. Haematologica. . PubMed
37. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
38. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
39. Pitsch J, et al. 2021. Ann Neurol. 89:666. PubMed
40. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
41. Ruer-Laventie J, et al. 2020. Bio Protoc. e3531:10. PubMed
42. Oladiran O, et al. 2021. J Neuroinflammation. 77:18. PubMed
43. Sinclair LV et al. 2019. Elife. 8 pii: e44210. PubMed
44. Ise W, et al. 2018. Immunity. 48:702. PubMed
45. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
46. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
47. Sun L, et al. 2021. Cell Reports. 35(9):109188. PubMed
48. Vishnoi M, et al. 2015. Sci Rep. 5: 17533. PubMed
49. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
50. Wang D, et al. 2020. J Cell Mol Med. 24:4212. PubMed
51. Alvim RG, et al. 2021. Molecules. 26:. PubMed
52. Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed
53. Anger-Góra N, et al. 2021. Oncol Lett. 22:582. PubMed
54. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
55. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
56. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
57. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
58. Jandke A, et al. 2020. Nat Commun. 3.075694444. PubMed
59. Chulkina M, et al. 2017. Eur J Pharmacol. 10.1016/j.ejphar.2017.06.033. PubMed
60. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
61. Jeljeli M, et al. 2021. Front Immunol. 12:670776. PubMed
62. Jing Y, et al. 2021. Front Immunol. 12:651860. PubMed
63. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
64. Zhao X, et al. 2022. iScience. 25:104690. PubMed
65. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
66. Limbach K, et al. 2017. Malar J. 10.1186/s12936-017-1911-z. PubMed
67. Yomtoubian S, et al. 2020. Cell Reports. 30(3):755-770.e6.. PubMed
68. Amezcua Vesely MC, et al. 2020. Cell. 178(5):1176-1188.e15.. PubMed
69. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
70. Jeon Y, et al. 2015. PLoS One. 10: e0139845. PubMed
71. Xu W, et al. 2019. Immunity. 51(5):826-839.e5. PubMed
72. Hendrikx S et al. 2019. Cell reports. 26(5):1227-1241 . PubMed
73. Field CS, et al. 2020. Cell Metab. 31:422. PubMed
74. Skirecki T, et al. 2020. JCI Insight. 5:. PubMed
75. Wang X, et al. 2022. Elife. 11:. PubMed
76. Malenica I, et al. 2021. Nat Commun. 12:5209. PubMed
77. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
78. Kitagawa K, et al. 2014. Mol Cell Biol. 34:2732. PubMed
79. Castillo–Azofeifa D, et al. 2019. EMBO J. 38:e99984. PubMed
80. Belogortseva N, et al. 2017. PLoS One.. 10.1371/journal.pone.0182825. PubMed
81. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
82. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
83. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
84. Pattabiraman D, et al. 2016. Science. 351: aad3680. PubMed
85. Miao Y et al. 2019. Cell. 177(5):1172-1186 . PubMed
86. Pan Y, et al. 2021. NPJ Vaccines. 6:1. PubMed
87. Aihara E, et al. 2015. Sci Rep. 5:17185. PubMed
88. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed

RRID

AB_830786 (BioLegend Cat. No. 103029)
AB_830787 (BioLegend Cat. No. 103030)

Antigen Details

Structure

Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD

Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function

Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM

Ligand/Receptor

Hyaluronan, MIP-1β, fibronectin, collagen

Cell Type

B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs

Biology Area

Cell Adhesion, Cell Biology, Immunology, Stem Cells

Molecular Family

Adhesion Molecules, CD Molecules

Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID

12505 View all products for this Gene ID 960 View all products for this Gene ID

UniProt

View information about CD44 on UniProt.org

Documentation

• Technical Data Sheet (pdf)
• Certificate of Analysis
• Material Safety Data Sheet

Reviews

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Related Pages & Pathways

Related FAQs

Other Formats

Certificate of Analysis